Epidemiological studies are known as “models”. Those are being produced at a rapid clip, and are being updated daily as we get more data. As with most models, they start out with huge error bars and get better over time.

Every epi would LOVE to have widespread test data, but we don’t. Oh well.

These antibody tests only became feasible in the past two weeks, when the tests were actually developed and validated, and then this test was run.

There’s a ton of science being done, if you stop and listen to what is being published.